[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Roche's Giredestrant shows a XX% reduced risk of recurrence or death in Phase X breast cancer trials, potentially offering a new oral alternative to injectables. The company also received EU approval for Gazyvaro in lupus nephritis, signaling advancements in multiple therapeutic areas.
This topic refers to the decentralized digital currency and its associated blockchain technology.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +43%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-03-12
1-Year Low: XXX on 2025-12-06
Engagements by network (24h): X: XXXXX
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XXXX%
X Month: XXX -XX%
X Months: XXXXX +130%
X Year: XXXXX +97%
1-Year High: XXX on 2025-08-03
1-Year Low: XX on 2025-01-27
Mentions by network (24h): X: XXX
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $rhhby in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXX -XX%
X Year: XXX +19%
1-Year High: XXX on 2025-03-06
1-Year Low: XX on 2025-09-15
The most influential creators that mention $rhhby in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Quantumup1 | X | XXXXX | X | XXXXX |
| @yaireinhorn | X | XXXXXX | X | XXX |
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @OzmosiHealth | X | XXXXX | X | XXX |
| @Roche | X | XXXXXXX | X | XX |
| @bioinvestor24 | X | XXXXX | X | XX |
| @ConnieHillCS | X | XXXXXX | X | XX |
| @HalevyMike | X | XXXXX | X | XX |
| @Reignots | X | XXXXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -X%
X Months: XX% +12%
X Year: XX% -X%
1-Year High: XXX% on 2025-01-27
1-Year Low: XX% on 2025-08-09
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$RHHBY Hoffmann-La Roche presented P3 Breast Cancer results on 2025-12-10 for Giredestrant More Info:"
X Link @OzmosiHealth 2025-12-11T18:33Z 3018 followers, XXX engagements
"Goldman Sachs $OLMA's PT to $XX from $XX and reiterated at a Buy rating. $RHHBY $NVS PFE AZN LLY ARVN H.C. WainwrightPT to $XX from $XX and reiterated at a Buy rating. Here's what the Analysts had to say:"
X Link @Quantumup1 2025-12-11T12:17Z 3928 followers, 1289 engagements
"π°Roche just dropped blockbuster Phase X data for its oral SERD in early breast cancer: XX% lower risk of recurrence or death vs standard endocrine therapy. First big oral alternative to injectables in decades. $RHHBY $ROG.SW This ones going to move the needle in HR+ breast cancer treatment"
X Link @PDUFA_Pulse 2025-12-10T20:53Z XXX followers, XXX engagements
"$SGMO #chronicpain #nonopioid #Fabry #HemA $LLY $ABBV $AZN $ALPMY $RHHBY $VRTX $PFE MethO made himself an exciting Xmas present added a few thousands more to his stash at these bargain levels and still not stopping here πππ«΅π½"
X Link @MethOSilly 2025-12-10T16:00Z XX followers, XXX engagements